Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
GMO Manual

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

General Medical Officer (GMO) Manual: Clinical Section

Subarachnoid Hemorrhage

Department of the Navy
Bureau of Medicine and Surgery

Peer Review Status: Internally Peer Reviewed

Introduction

Lumbar puncture

Management of seizures

Subarachnoid Hemorrhage

Definitive treatment

Environmental management

Diagnosis

Initial management

Disposition

Neurologic exam

Electrolyte abnormalities

Hunt Classification of SAH

Diagnostic studies

Other considerations

Introduction

Neurosurgical emergencies frequently are initiated by increased intracranial pressure (ICP). Some causes of increased intracranial pressure (ICP) may be directly related to a cerebral mass. Acute obstructive hydrocephalus, occurring from a variety of etiologies, may cause elevations in ICP. Treatment of patients with increased intracranial pressure follows the same guidelines as the care for any critically ill patient, namely: establishing an airway, breathing for the patient if necessary, and supporting circulation. Additional benefit for the patient can be gained by the use of osmotic agents to help alter the intracranial pressure. The following information outlines the more typical cases of neurosurgical emergencies which might be expected while caring for an active duty population.

Subarachnoid Hemorrhage

One source of rapid elevation of intracranial pressure is subarachnoid hemorrhage (SAH). The leading cause for SAH is trauma. Those patients without a history of trauma usually bleed into their subarachnoid space from aneurysms, arteriovenous malformations (AVM), tumors, strokes, etc. The more common causes of nontraumatic SAH are aneurysms and AVMs.

Diagnosis

The diagnosis is made by documenting historical findings to include an excruciating headache, coupled with photophobia, nausea, and vomiting. Any of these symptoms may be present in other medical conditions and are not prerequisites. Patients may have mild headache initially, without photophobia. Patients’ exams may vary considerably from those that present with mild headache to those that present in coma. The cardinal sign of basilar meningeal irritation is a stiff neck. Frequently patients with a SAH will present with some evidence of neck stiffness. Upon examination many times the patient will prefer to keep their eyes closed for comfort, will have rigid board-like neck stiffness, and may be nauseated. Elevation of blood pressure may also be remarkable even with young patients.

Neurologic exam

Neurologic examination should pursue abnormalities in any of the following areas: mental status, cranial nerves, motor and sensory exams, or cerebellar function. Patients may be obtunded due to the irritating effect of subarachnoid blood, however other patients may only have a mild headache. The third nerve cranial nerve is most commonly affected. The patient may present with ptosis and a dilated pupil (due to 3rd nerve compression from an expanding posterior communicating aneurysm). Unilateral hemiparesis may represent the presence of a hematoma from hemorrhage into the cerebral cortex from an aneurysm. Similarly, the patient may have signs of mass effect, seizures, or other focal abnormalities from a large clot. More often than not, however, the patient has evidence of generalized cortical dysfunction manifested by depression in the level of consciousness. Ocular hemorrhages are common in SAH, occurring in up to 25 percent of cases. The hemorrhage can be subhyaloid (preretinal) seen as a bright red spot near the optic disc, intraretinal surrounding the fovea, or within the vitreous humor (Terson’s syndrome).

Diagnostic studies

Diagnosis is simplified by rapid sequence CT scanning, when available. However, aboard ships other than the USNS Comfort or Mercy, scanning is not available, and therefore secondary procedures must be relied upon. Certainly even when CT scanning is negative and the suspicion is high, lumbar puncture is used for diagnosis. The major complication of lumbar puncture is causing an alteration in the transmural pressure of the aneurysm, causing it to re-hemorrhage, with usually catastrophic results.

Therefore, if CT is available ashore, and logistics allow for transportation, then scanning should always be performed first. If this is impossible, the use lumbar puncture in the diagnosis is justified.

Lumbar puncture

Confusion frequently arises from a bloody lumbar puncture. If the bloody CSF clears as the second and third tubes of CSF are collected, and if the fluid is found to be xanthochromic after centrifugation of the tubes, then the likelihood that the patient had a SAH is high. However if the fluid never clears, and the fluid is clear after centrifugation then the patient most likely did not have a SAH. However, it is theoretically possible to perform a lumbar puncture on a patient and find clear CSF (i.e., no xanthochromia) if the lumbar puncture is performed very early on. Therefore, if the suspicion remains that the patient had a SAH, after CSF is drawn that shows no xanthochromia, then the patient should be treated as though he or she had a SAH.

Definitive treatment

The definitive treatment of a patient with a SAH from an aneurysm or AVM is surgery. Obviously, logistics may not allow for immediate transfer of the patient to the care of a neurosurgeon. It is difficult at times to differentiate between a SAH of an aneurysm and AVM, and therefore guidelines must be adhered to which deal with a worst case scenario. The guidelines that follow therefore will deal with a hypothetical patient who had a SAH from an aneurysmal bleed. The possibility of re-rupture in these patients is more dangerous than with a patient with an AVM.

Initial management

The ABCs must be evaluated and stabilized. In general, the use of hyperventilation in aneurysm patients is to be avoided in light of the possibility of compounding the ischemic effects of vasospasm. PCO2 levels should be maintained between 31-35mm if hyperventilation is to be used. If mass effect still threatens the patient, then dehydrating agents such as Mannitol or Lasix may be used. We generally use Mannitolin lower doses of 0.25mg/kg, since the dehydration effect is obtained without causing prerenal shutdown from hypovolemia.

Electrolyte abnormalities

Patients with SAH frequently may have abnormalities of their electrolytes, most commonly with hyponatremia. Low sodium may lead to exacerbation of seizures, which if the sodium is low enough may make the seizures extremely difficult to treat. As stated before, the general idea is not to fluid restrict these patients, and although the patient may be considered to have the syndrome of inappropriate antidiuretic hormone (SIADH), it is probably best to treat these patients with 3% saline solution as opposed to fluid restriction. IV fluids should at least be kept at maintenance levels unless the patient is demonstrating signs of incipient herniation. Vigilance must be maintained to verify that calcium and magnesium levels are not too low, since low levels may also precipitate seizures.

Other considerations

Cardiac arrhythmias may occur with SAH. Close monitoring in the initial stages of SAH (at least 48 hours), will help signal the need for therapy in these particular patients. Hypertension (systolic blood pressure greater than 180 mm Hg) may also be extremely difficult to treat, at times requiring either the use of nipride or nitroglycerin, labetalol, or hydralazine. Systolic blood pressure should be kept to a maximum of 155 mm Hg in the scenario of SAH from aneurysmal rupture. Many times pain treatment will assist with the control of hypertension. We prefer IV morphine because of its analgesic control and because it can be easily reversed to allow for an accurate neurologic exam.

Management of seizures

Seizures must be treated with patients who had a SAH. In general, unless contraindicated, we treat patients with Dilantin. The loading dose for this drug is 15mg/kg and should not be given too rapidly due to the potential for complete heart block. Some neurosurgeons prefer phenobarbital, in light of its sedating effect, its effect on blood pressure, as well as seizure control. Phenobarbital can be given in 30mg aliquots with the upper limit of adequate levels around 300mg loading dose. Care must be maintained at high levels for respiratory arrest.

Environmental management

Because one of the biggest fears is rebleeding, patients should be kept comfortable, in darkened and quiet surroundings, with stool softeners, and in an environment that is as nonstressful as possible. Pain control can assist in making patients as comfortable as possible.

Disposition

The objective should be eventual transfer to a medical facility where neurosurgical capabilities are present. Air evacuation is possible depending on logistics and the presence tertiary medical facilities. Using a Hunt classification of SAH severity for description may provide further valuable information for a neurosurgical colleague.

Hunt Classification of SAH

Grade

Description

0

never bled

1

mild headache, slight meningismus

2

severe headache with meningismus

3

all above plus focal deficit or depression in LOC

4

all above plus obtunded or stuporous

5

moribund, not expected to survive

LOC = level of consciousness

Reviewed and revised by CDR Robert Heim, MC, USN, Neurosurgery Specialty Leader and Staff Neurosurgeon, National Naval Medical Center, Bethesda, MD. (1999).


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

 

Advertise on this site